hydromorphone has been researched along with Pain, Chronic in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 25 (83.33) | 24.3611 |
| 2020's | 5 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Carayannopoulos, AG; Gaudet, D; Grande, G; Leary, OP; Scarfo, KA | 1 |
| Heck, J; Krause, O; Stichtenoth, DO | 1 |
| Bergeria, CL; Campbell, CM; Dunn, KE; Hamilton, KR; Huhn, AS; Mun, CJ; Speed, TJ; Vandrey, R | 1 |
| Balasanova, AA; Crum, IT; Meyer Karre, VM | 1 |
| Li, J; Paik, JM; Triantafylidis, LK; Zhuo, M | 1 |
| Bayer, O; Heid, F; Laufenberg-Feldmann, R; Schuster, M | 1 |
| Aner, M; Petro, J; Urits, I; Viswanath, O | 1 |
| Rotchford, JK | 1 |
| Falke, D; Gálvez, R; Hans, G; Schäfer, M; Steigerwald, I | 1 |
| Coaccioli, S; Crapa, ME; Di Cato, L; Marinangeli, F; Paladini, A; Panaccione, A; Piroli, A | 1 |
| Casali, M; Dauri, M; Lazzari, M; Sabato, AF; Sabato, E; Tufaro, G | 1 |
| Blimke, B; Giesecke, T; Hesselbarth, S; Müller-Schwefe, GH | 1 |
| Eisenberg, E; Haddad, M; Pud, D; Suzan, E; Treister, R | 2 |
| López-Pérez, FJ; Mínguez-Martí, A; Ortega-García, MP; Pastor-Clérigues, A; Sanfeliu-García, J; Vicario-Sánchez, E | 1 |
| Bernardy, K; Häuser, W; Maier, C | 1 |
| Duse, G; Ferrari, R; Visentin, M; Zanolin, ME | 1 |
| Maritz, MA; Nold, GE; Rey, H; Schumann, C; Schwittay, A | 1 |
| Aldington, D; Cole, P; Cooper, TE; Derry, S; Gaskell, H; Knaggs, R; Moore, RA; Stannard, C; Wiffen, PJ | 1 |
| Broglio, K; Walsh, AF | 1 |
| Burns, J; Comstock, K; Connolly, S; Gerson, T; Harden, RN; Khazey, K; Kirsling, A; Saracoglu, M | 1 |
| Lahajnar Čavlović, S; Pirc, J; Stepanović, A | 1 |
| Kahan, M; Mailis-Gagnon, A; Srivastava, A; Wilson, L | 1 |
| Janecek, E; Kahan, M; Resnick, A; Sheehan, C; Srivastava, A; Wenghofer, EF; Wilson, L | 1 |
| Gallagher, R | 1 |
| Cruciani, RA; Katz, N; Portenoy, RK | 1 |
| Binsfeld, H; Richarz, U; Sabatowski, R; Szczepanski, L; Waechter, S | 1 |
| Atayee, RS; Best, BM; Hughes, MM; Pesce, AJ | 1 |
| Atayee, RS; Barakat, NH; Best, BM; Pesce, AJ | 1 |
| Hale, ME; Kutch, M; Nalamachu, SR | 1 |
6 review(s) available for hydromorphone and Pain, Chronic
| Article | Year |
|---|---|
Opioid Use in the Nondialysis Chronic Kidney Disease Population.
Topics: Analgesics, Opioid; Chronic Pain; Fentanyl; Humans; Hydromorphone; Practice Patterns, Physicians'; Renal Insufficiency, Chronic | 2021 |
Opioid Rotation in Cancer Pain Treatment.
Topics: Analgesics, Opioid; Buprenorphine; Cancer Pain; Chronic Pain; Fentanyl; Germany; Humans; Hydromorphone; Morphine; Neoplasms; Oxycodone; Pain Management | 2018 |
[Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks].
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Hydromorphone; Long-Term Care; Morphine; Oxycodone; Oxymorphone; Pain Measurement; Phenols; Randomized Controlled Trials as Topic; Tapentadol; Tramadol; Treatment Outcome | 2015 |
Hydromorphone for neuropathic pain in adults.
Topics: Adult; Analgesics, Opioid; Chronic Pain; Humans; Hydromorphone; Neuralgia; Randomized Controlled Trials as Topic | 2016 |
Pain Management in the Individual with Serious Illness and Comorbid Substance Use Disorder.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Comorbidity; Humans; Hydromorphone; Middle Aged; Opioid-Related Disorders; Pain Management; Pain Measurement; United States | 2016 |
Safety and Tolerability of Once-Daily OROS(®) hydromorphone extended-release in opioid-tolerant adults with moderate-to-severe chronic cancer and noncancer pain: pooled analysis of 11 clinical studies.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Disease; Chronic Pain; Clinical Trials as Topic; Comorbidity; Evidence-Based Medicine; Female; Humans; Hydromorphone; Incidence; Male; Middle Aged; Neoplasms; Opioid-Related Disorders; Risk Assessment; Risk Factors; Severity of Illness Index; Sex Distribution; United States; Young Adult | 2012 |
9 trial(s) available for hydromorphone and Pain, Chronic
| Article | Year |
|---|---|
Within-subject, double-blind, randomized, placebo-controlled evaluation of combining the cannabinoid dronabinol and the opioid hydromorphone in adults with chronic pain.
Topics: Adult; Analgesics; Analgesics, Opioid; Cannabinoids; Chronic Pain; Double-Blind Method; Dronabinol; Female; Humans; Hydromorphone; Male; Middle Aged; Osteoarthritis, Knee | 2023 |
Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study.
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Chronic Pain; Constipation; Delayed-Action Preparations; Female; Fentanyl; Humans; Hydromorphone; Low Back Pain; Male; Middle Aged; Morphine; Neuralgia; Oxycodone; Pain Measurement; Phenols; Severity of Illness Index; Tapentadol | 2013 |
[Oral osmotic hydromorphone (OROS) in patients with chronic severe pain due to osteoarthritis under daily routine conditions].
Topics: Activities of Daily Living; Administration, Oral; Aged; Analgesics, Opioid; Chronic Pain; Disability Evaluation; Dose-Response Relationship, Drug; Female; Germany; Humans; Hydromorphone; Male; Middle Aged; Osteoarthritis; Pain Measurement; Patient Satisfaction; Retrospective Studies; Sleep | 2014 |
The effect of hydromorphone therapy on psychophysical measurements of the descending inhibitory pain systems in patients with chronic radicular pain.
Topics: Adult; Aged; Analgesics, Opioid; Chronic Pain; Conditioning, Psychological; Female; Humans; Hydromorphone; Male; Middle Aged; Physical Stimulation; Psychophysics; Radiculopathy; Young Adult | 2015 |
Efficacy of a new once daily hydromorphone formulation in comparison with twice daily administration in chronic pain: a randomized, double-blind, cross-over study.
Topics: Adult; Aged; Analgesics, Opioid; Chronic Pain; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Female; Headache; Humans; Hydromorphone; Male; Middle Aged; Nausea; Pain Measurement | 2016 |
"Managing" the Placebo Effect: The Single-Blind Placebo Lead-in Response in Two Pain Models.
Topics: Adult; Aged; Analgesics; Chronic Pain; Cyclopropanes; Double-Blind Method; Female; Humans; Hydromorphone; Low Back Pain; Male; Middle Aged; Milnacipran; Osteoarthritis, Knee; Pain Measurement; Pilot Projects; Placebo Effect; Research Design; Single-Blind Method | 2016 |
Dose equivalence of immediate-release hydromorphone and once-daily osmotic-controlled extended-release hydromorphone: a randomized, double-blind trial incorporating a measure of assay sensitivity.
Topics: Adult; Aged; Analgesia; Analgesics, Opioid; Breakthrough Pain; Chronic Pain; Double-Blind Method; Female; Humans; Hydromorphone; Male; Middle Aged; Patient Selection | 2012 |
Sustained safety and efficacy of once-daily hydromorphone extended-release (OROS® hydromorphone ER) compared with twice-daily oxycodone controlled-release over 52 weeks in patients with moderate to severe chronic noncancer pain.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Drug Administration Schedule; Drug Delivery Systems; Emotions; Female; Follow-Up Studies; Humans; Hydromorphone; Male; Middle Aged; Oxycodone; Pain Measurement; Quality of Life; Sleep Wake Disorders; Time Factors; Treatment Outcome | 2013 |
A negative correlation between hyperalgesia and analgesia in patients with chronic radicular pain: is hydromorphone therapy a double-edged sword?
Topics: Adult; Aged; Analgesics, Opioid; Chronic Pain; Female; Humans; Hydromorphone; Hyperalgesia; Male; Middle Aged; Radiculopathy; Young Adult | 2013 |
15 other study(ies) available for hydromorphone and Pain, Chronic
| Article | Year |
|---|---|
Transition from Compounded to Monotherapy Intrathecal Pain Medication Reduces Drug Costs: Retrospective Analysis of Patient Billing Data.
Topics: Bupivacaine; Chronic Pain; Humans; Hydromorphone; Pharmaceutical Preparations; Retrospective Studies; United States | 2021 |
[86-year-old lady with persisting pain].
Topics: Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Female; Humans; Hydrocortisone; Hydromorphone; Medication Errors; Terminology as Topic | 2021 |
Transitioning From Intrathecal Hydromorphone to Sublingual Buprenorphine-Naloxone Through Microdosing: A Case Report.
Topics: Aged; Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Chronic Pain; Female; Humans; Hydromorphone | 2020 |
Retrograde placement of an intrathecal catheter for chronic low pelvic cancer pain.
Topics: Bupivacaine; Cancer Pain; Catheterization; Chronic Pain; Colonic Neoplasms; Fluoroscopy; Humans; Hydromorphone; Infusion Pumps, Implantable; Infusions, Spinal; Male; Middle Aged; Pain Management; Spine; Treatment Outcome | 2019 |
Acute suicidal ideations responsive to hydromorphone.
Topics: Aged; Bipolar Disorder; Chronic Pain; Depression; Female; Humans; Hydromorphone; Narcotics; Suicidal Ideation; Suicide, Attempted; Treatment Outcome | 2019 |
Hydromorphone does not influence the immune response in patients affected by chronic pain.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Female; Humans; Hydromorphone; Immunity, Cellular; Male; Middle Aged | 2013 |
Long-term efficacy of OROS® hydromorphone combined with pregabalin for chronic non-cancer neuropathic pain.
Topics: Adult; Aged; Aged, 80 and over; Chronic Pain; Drug Tolerance; Drug-Related Side Effects and Adverse Reactions; Female; gamma-Aminobutyric Acid; Humans; Hydromorphone; Male; Middle Aged; Neuralgia; Pain Management; Pregabalin; Young Adult | 2014 |
[Clinical experience in opioid switch for noncancer chronic pain treatment].
Topics: Adjuvants, Pharmaceutic; Administration, Oral; Aged; Aged, 80 and over; Analgesia, Epidural; Analgesics, Opioid; Chills; Chronic Pain; Constipation; Drug Substitution; Female; Fentanyl; Humans; Hydromorphone; Infusions, Parenteral; Male; Middle Aged; Morphine; Retrospective Studies; Therapeutic Equivalency; Transdermal Patch; Visual Analog Scale | 2014 |
Effectiveness of opioid analgesics in chronic noncancer pain.
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Chronic Pain; Female; Fentanyl; Humans; Hydromorphone; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Opioid-Related Disorders; Oxycodone; Pain Clinics; Pain Measurement; Personality; Phenols; Prospective Studies; Quality of Life; Surveys and Questionnaires; Tapentadol; Treatment Outcome | 2015 |
Clinical efficacy of OROS® hydromorphone in patients suffering from severe chronic pain: A Study undertaken in routine clinical practice.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Dose-Response Relationship, Drug; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Pain Measurement; Quality of Life; Slovenia; Treatment Outcome | 2011 |
Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population.
Topics: Analgesics, Opioid; Benzodiazepines; Canada; Chronic Pain; Codeine; Humans; Hydromorphone; Mass Screening; Opioid-Related Disorders; Oxycodone; Patient Education as Topic; Sleep Apnea Syndromes; Tramadol | 2011 |
Pharmacists' experiences with dispensing opioids: provincial survey.
Topics: Adult; Aged; Alcohol Drinking; Analgesics, Opioid; Chronic Pain; Codeine; Data Collection; Drug Prescriptions; Drug-Seeking Behavior; Female; Health Knowledge, Attitudes, Practice; Humans; Hydromorphone; Hypnotics and Sedatives; Interdisciplinary Communication; Interprofessional Relations; Male; Medication Adherence; Middle Aged; Ontario; Oxycodone; Pharmacists; Practice Patterns, Physicians' | 2011 |
Swallowing difficulties: a prognostic signpost.
Topics: Aged, 80 and over; Analgesics, Opioid; Antipsychotic Agents; Back Pain; Chronic Pain; Deglutition Disorders; Dementia; Female; Humans; Hydromorphone; Loxapine; Palliative Care; Pneumonia, Aspiration; Prognosis; Psychomotor Agitation | 2011 |
Observations on the metabolism of morphine to hydromorphone in pain patients.
Topics: Analgesics, Opioid; Chromatography, High Pressure Liquid; Chronic Pain; Databases, Factual; Dose-Response Relationship, Drug; Humans; Hydromorphone; Mass Spectrometry; Morphine; Retrospective Studies; Time Factors | 2012 |
Relationship between the concentration of hydrocodone and its conversion to hydromorphone in chronic pain patients using urinary excretion data.
Topics: Analgesics, Opioid; Chromatography, High Pressure Liquid; Chronic Pain; Drug Monitoring; Humans; Hydrocodone; Hydromorphone; Reference Values; Reproducibility of Results; Retrospective Studies; Tandem Mass Spectrometry; Time Factors | 2012 |